Click for best price
Psychedelic Drugs Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Psychedelic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psychedelic Drugs. This report contains market size and forecasts of Psychedelic Drugs in global, including the following market information:
Global Psychedelic Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Psychedelic Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Psilocybin Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Psychedelic Drugs include COMPASS Pathways PLC, Pfizer, Eli Lilly, GlaxoSmithKline, Cybin Inc, Field Trip Health, ATAI Life Sciences, NUMINUS WELLNESS and MindMed, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Psychedelic Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Psychedelic Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Psychedelic Drugs Market Segment Percentages, by Type, 2022 (%)
Psilocybin
LSD
MDMA
DMT
Ketamine
Others
Global Psychedelic Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Psychedelic Drugs Market Segment Percentages, by Application, 2022 (%)
Depressive Disorders
Post-Traumatic Stress Disorders
Substance Abuse Disorders
Obsessive Compulsive Disorders
Others
Global Psychedelic Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Psychedelic Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Psychedelic Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Psychedelic Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
COMPASS Pathways PLC
Pfizer
Eli Lilly
GlaxoSmithKline
Cybin Inc
Field Trip Health
ATAI Life Sciences
NUMINUS WELLNESS
MindMed
HAVN Life Sciences
Seelos Therapeutics
Jannsen
Acadia Pharmaceuticals
Intellipharmaceutics
Revive Therapeutics
Mydecine Innovations Group
Red Light Holland
Braxia Scientific
Mind Cure Health
Entheon Biomedical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Psychedelic Drugs, market overview.
Chapter 2: Global Psychedelic Drugs market size in revenue.
Chapter 3: Detailed analysis of Psychedelic Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Psychedelic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Psychedelic Drugs Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
118 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Psychedelic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Psychedelic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Psychedelic Drugs Overall Market Size
2.1 Global Psychedelic Drugs Market Size: 2022 VS 2030
2.2 Global Psychedelic Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Psychedelic Drugs Players in Global Market
3.2 Top Global Psychedelic Drugs Companies Ranked by Revenue
3.3 Global Psychedelic Drugs Revenue by Companies
3.4 Top 3 and Top 5 Psychedelic Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Psychedelic Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Psychedelic Drugs Players in Global Market
3.6.1 List of Global Tier 1 Psychedelic Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Psychedelic Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Psychedelic Drugs Market Size Markets, 2022 & 2030
4.1.2 Psilocybin
4.1.3 LSD
4.1.4 MDMA
4.1.5 DMT
4.1.6 Ketamine
4.1.7 Others
4.2 By Type - Global Psychedelic Drugs Revenue & Forecasts
4.2.1 By Type - Global Psychedelic Drugs Revenue, 2018-2023
4.2.2 By Type - Global Psychedelic Drugs Revenue, 2024-2030
4.2.3 By Type - Global Psychedelic Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Psychedelic Drugs Market Size, 2022 & 2030
5.1.2 Depressive Disorders
5.1.3 Post-Traumatic Stress Disorders
5.1.4 Substance Abuse Disorders
5.1.5 Obsessive Compulsive Disorders
5.1.6 Others
5.2 By Application - Global Psychedelic Drugs Revenue & Forecasts
5.2.1 By Application - Global Psychedelic Drugs Revenue, 2018-2023
5.2.2 By Application - Global Psychedelic Drugs Revenue, 2024-2030
5.2.3 By Application - Global Psychedelic Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Psychedelic Drugs Market Size, 2022 & 2030
6.2 By Region - Global Psychedelic Drugs Revenue & Forecasts
6.2.1 By Region - Global Psychedelic Drugs Revenue, 2018-2023
6.2.2 By Region - Global Psychedelic Drugs Revenue, 2024-2030
6.2.3 By Region - Global Psychedelic Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Psychedelic Drugs Revenue, 2018-2030
6.3.2 US Psychedelic Drugs Market Size, 2018-2030
6.3.3 Canada Psychedelic Drugs Market Size, 2018-2030
6.3.4 Mexico Psychedelic Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Psychedelic Drugs Revenue, 2018-2030
6.4.2 Germany Psychedelic Drugs Market Size, 2018-2030
6.4.3 France Psychedelic Drugs Market Size, 2018-2030
6.4.4 U.K. Psychedelic Drugs Market Size, 2018-2030
6.4.5 Italy Psychedelic Drugs Market Size, 2018-2030
6.4.6 Russia Psychedelic Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Psychedelic Drugs Market Size, 2018-2030
6.4.8 Benelux Psychedelic Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Psychedelic Drugs Revenue, 2018-2030
6.5.2 China Psychedelic Drugs Market Size, 2018-2030
6.5.3 Japan Psychedelic Drugs Market Size, 2018-2030
6.5.4 South Korea Psychedelic Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Psychedelic Drugs Market Size, 2018-2030
6.5.6 India Psychedelic Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Psychedelic Drugs Revenue, 2018-2030
6.6.2 Brazil Psychedelic Drugs Market Size, 2018-2030
6.6.3 Argentina Psychedelic Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Psychedelic Drugs Revenue, 2018-2030
6.7.2 Turkey Psychedelic Drugs Market Size, 2018-2030
6.7.3 Israel Psychedelic Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Psychedelic Drugs Market Size, 2018-2030
6.7.5 UAE Psychedelic Drugs Market Size, 2018-2030
7 Psychedelic Drugs Companies Profiles
7.1 COMPASS Pathways PLC
7.1.1 COMPASS Pathways PLC Company Summary
7.1.2 COMPASS Pathways PLC Business Overview
7.1.3 COMPASS Pathways PLC Psychedelic Drugs Major Product Offerings
7.1.4 COMPASS Pathways PLC Psychedelic Drugs Revenue in Global Market (2018-2023)
7.1.5 COMPASS Pathways PLC Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Psychedelic Drugs Major Product Offerings
7.2.4 Pfizer Psychedelic Drugs Revenue in Global Market (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Eli Lilly
7.3.1 Eli Lilly Company Summary
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Psychedelic Drugs Major Product Offerings
7.3.4 Eli Lilly Psychedelic Drugs Revenue in Global Market (2018-2023)
7.3.5 Eli Lilly Key News & Latest Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Psychedelic Drugs Major Product Offerings
7.4.4 GlaxoSmithKline Psychedelic Drugs Revenue in Global Market (2018-2023)
7.4.5 GlaxoSmithKline Key News & Latest Developments
7.5 Cybin Inc
7.5.1 Cybin Inc Company Summary
7.5.2 Cybin Inc Business Overview
7.5.3 Cybin Inc Psychedelic Drugs Major Product Offerings
7.5.4 Cybin Inc Psychedelic Drugs Revenue in Global Market (2018-2023)
7.5.5 Cybin Inc Key News & Latest Developments
7.6 Field Trip Health
7.6.1 Field Trip Health Company Summary
7.6.2 Field Trip Health Business Overview
7.6.3 Field Trip Health Psychedelic Drugs Major Product Offerings
7.6.4 Field Trip Health Psychedelic Drugs Revenue in Global Market (2018-2023)
7.6.5 Field Trip Health Key News & Latest Developments
7.7 ATAI Life Sciences
7.7.1 ATAI Life Sciences Company Summary
7.7.2 ATAI Life Sciences Business Overview
7.7.3 ATAI Life Sciences Psychedelic Drugs Major Product Offerings
7.7.4 ATAI Life Sciences Psychedelic Drugs Revenue in Global Market (2018-2023)
7.7.5 ATAI Life Sciences Key News & Latest Developments
7.8 NUMINUS WELLNESS
7.8.1 NUMINUS WELLNESS Company Summary
7.8.2 NUMINUS WELLNESS Business Overview
7.8.3 NUMINUS WELLNESS Psychedelic Drugs Major Product Offerings
7.8.4 NUMINUS WELLNESS Psychedelic Drugs Revenue in Global Market (2018-2023)
7.8.5 NUMINUS WELLNESS Key News & Latest Developments
7.9 MindMed
7.9.1 MindMed Company Summary
7.9.2 MindMed Business Overview
7.9.3 MindMed Psychedelic Drugs Major Product Offerings
7.9.4 MindMed Psychedelic Drugs Revenue in Global Market (2018-2023)
7.9.5 MindMed Key News & Latest Developments
7.10 HAVN Life Sciences
7.10.1 HAVN Life Sciences Company Summary
7.10.2 HAVN Life Sciences Business Overview
7.10.3 HAVN Life Sciences Psychedelic Drugs Major Product Offerings
7.10.4 HAVN Life Sciences Psychedelic Drugs Revenue in Global Market (2018-2023)
7.10.5 HAVN Life Sciences Key News & Latest Developments
7.11 Seelos Therapeutics
7.11.1 Seelos Therapeutics Company Summary
7.11.2 Seelos Therapeutics Business Overview
7.11.3 Seelos Therapeutics Psychedelic Drugs Major Product Offerings
7.11.4 Seelos Therapeutics Psychedelic Drugs Revenue in Global Market (2018-2023)
7.11.5 Seelos Therapeutics Key News & Latest Developments
7.12 Jannsen
7.12.1 Jannsen Company Summary
7.12.2 Jannsen Business Overview
7.12.3 Jannsen Psychedelic Drugs Major Product Offerings
7.12.4 Jannsen Psychedelic Drugs Revenue in Global Market (2018-2023)
7.12.5 Jannsen Key News & Latest Developments
7.13 Acadia Pharmaceuticals
7.13.1 Acadia Pharmaceuticals Company Summary
7.13.2 Acadia Pharmaceuticals Business Overview
7.13.3 Acadia Pharmaceuticals Psychedelic Drugs Major Product Offerings
7.13.4 Acadia Pharmaceuticals Psychedelic Drugs Revenue in Global Market (2018-2023)
7.13.5 Acadia Pharmaceuticals Key News & Latest Developments
7.14 Intellipharmaceutics
7.14.1 Intellipharmaceutics Company Summary
7.14.2 Intellipharmaceutics Business Overview
7.14.3 Intellipharmaceutics Psychedelic Drugs Major Product Offerings
7.14.4 Intellipharmaceutics Psychedelic Drugs Revenue in Global Market (2018-2023)
7.14.5 Intellipharmaceutics Key News & Latest Developments
7.15 Revive Therapeutics
7.15.1 Revive Therapeutics Company Summary
7.15.2 Revive Therapeutics Business Overview
7.15.3 Revive Therapeutics Psychedelic Drugs Major Product Offerings
7.15.4 Revive Therapeutics Psychedelic Drugs Revenue in Global Market (2018-2023)
7.15.5 Revive Therapeutics Key News & Latest Developments
7.16 Mydecine Innovations Group
7.16.1 Mydecine Innovations Group Company Summary
7.16.2 Mydecine Innovations Group Business Overview
7.16.3 Mydecine Innovations Group Psychedelic Drugs Major Product Offerings
7.16.4 Mydecine Innovations Group Psychedelic Drugs Revenue in Global Market (2018-2023)
7.16.5 Mydecine Innovations Group Key News & Latest Developments
7.17 Red Light Holland
7.17.1 Red Light Holland Company Summary
7.17.2 Red Light Holland Business Overview
7.17.3 Red Light Holland Psychedelic Drugs Major Product Offerings
7.17.4 Red Light Holland Psychedelic Drugs Revenue in Global Market (2018-2023)
7.17.5 Red Light Holland Key News & Latest Developments
7.18 Braxia Scientific
7.18.1 Braxia Scientific Company Summary
7.18.2 Braxia Scientific Business Overview
7.18.3 Braxia Scientific Psychedelic Drugs Major Product Offerings
7.18.4 Braxia Scientific Psychedelic Drugs Revenue in Global Market (2018-2023)
7.18.5 Braxia Scientific Key News & Latest Developments
7.19 Mind Cure Health
7.19.1 Mind Cure Health Company Summary
7.19.2 Mind Cure Health Business Overview
7.19.3 Mind Cure Health Psychedelic Drugs Major Product Offerings
7.19.4 Mind Cure Health Psychedelic Drugs Revenue in Global Market (2018-2023)
7.19.5 Mind Cure Health Key News & Latest Developments
7.20 Entheon Biomedical
7.20.1 Entheon Biomedical Company Summary
7.20.2 Entheon Biomedical Business Overview
7.20.3 Entheon Biomedical Psychedelic Drugs Major Product Offerings
7.20.4 Entheon Biomedical Psychedelic Drugs Revenue in Global Market (2018-2023)
7.20.5 Entheon Biomedical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Psychedelic Drugs Market Opportunities & Trends in Global Market
Table 2. Psychedelic Drugs Market Drivers in Global Market
Table 3. Psychedelic Drugs Market Restraints in Global Market
Table 4. Key Players of Psychedelic Drugs in Global Market
Table 5. Top Psychedelic Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Psychedelic Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Psychedelic Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Psychedelic Drugs Product Type
Table 9. List of Global Tier 1 Psychedelic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Psychedelic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Psychedelic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Psychedelic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Psychedelic Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Psychedelic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Psychedelic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Psychedelic Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Psychedelic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Psychedelic Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Psychedelic Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Psychedelic Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Psychedelic Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Psychedelic Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Psychedelic Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Psychedelic Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Psychedelic Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Psychedelic Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Psychedelic Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Psychedelic Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Psychedelic Drugs Revenue, (US$, Mn), 2024-2030
Table 30. COMPASS Pathways PLC Company Summary
Table 31. COMPASS Pathways PLC Psychedelic Drugs Product Offerings
Table 32. COMPASS Pathways PLC Psychedelic Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. COMPASS Pathways PLC Key News & Latest Developments
Table 34. Pfizer Company Summary
Table 35. Pfizer Psychedelic Drugs Product Offerings
Table 36. Pfizer Psychedelic Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer Key News & Latest Developments
Table 38. Eli Lilly Company Summary
Table 39. Eli Lilly Psychedelic Drugs Product Offerings
Table 40. Eli Lilly Psychedelic Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Eli Lilly Key News & Latest Developments
Table 42. GlaxoSmithKline Company Summary
Table 43. GlaxoSmithKline Psychedelic Drugs Product Offerings
Table 44. GlaxoSmithKline Psychedelic Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. GlaxoSmithKline Key News & Latest Developments
Table 46. Cybin Inc Company Summary
Table 47. Cybin Inc Psychedelic Drugs Product Offerings
Table 48. Cybin Inc Psychedelic Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Cybin Inc Key News & Latest Developments
Table 50. Field Trip Health Company Summary
Table 51. Field Trip Health Psychedelic Drugs Product Offerings
Table 52. Field Trip Health Psychedelic Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Field Trip Health Key News & Latest Developments
Table 54. ATAI Life Sciences Company Summary
Table 55. ATAI Life Sciences Psychedelic Drugs Product Offerings
Table 56. ATAI Life Sciences Psychedelic Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. ATAI Life Sciences Key News & Latest Developments
Table 58. NUMINUS WELLNESS Company Summary
Table 59. NUMINUS WELLNESS Psychedelic Drugs Product Offerings
Table 60. NUMINUS WELLNESS Psychedelic Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. NUMINUS WELLNESS Key News & Latest Developments
Table 62. MindMed Company Summary
Table 63. MindMed Psychedelic Drugs Product Offerings
Table 64. MindMed Psychedelic Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. MindMed Key News & Latest Developments
Table 66. HAVN Life Sciences Company Summary
Table 67. HAVN Life Sciences Psychedelic Drugs Product Offerings
Table 68. HAVN Life Sciences Psychedelic Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. HAVN Life Sciences Key News & Latest Developments
Table 70. Seelos Therapeutics Company Summary
Table 71. Seelos Therapeutics Psychedelic Drugs Product Offerings
Table 72. Seelos Therapeutics Psychedelic Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Seelos Therapeutics Key News & Latest Developments
Table 74. Jannsen Company Summary
Table 75. Jannsen Psychedelic Drugs Product Offerings
Table 76. Jannsen Psychedelic Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Jannsen Key News & Latest Developments
Table 78. Acadia Pharmaceuticals Company Summary
Table 79. Acadia Pharmaceuticals Psychedelic Drugs Product Offerings
Table 80. Acadia Pharmaceuticals Psychedelic Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. Acadia Pharmaceuticals Key News & Latest Developments
Table 82. Intellipharmaceutics Company Summary
Table 83. Intellipharmaceutics Psychedelic Drugs Product Offerings
Table 84. Intellipharmaceutics Psychedelic Drugs Revenue (US$, Mn) & (2018-2023)
Table 85. Intellipharmaceutics Key News & Latest Developments
Table 86. Revive Therapeutics Company Summary
Table 87. Revive Therapeutics Psychedelic Drugs Product Offerings
Table 88. Revive Therapeutics Psychedelic Drugs Revenue (US$, Mn) & (2018-2023)
Table 89. Revive Therapeutics Key News & Latest Developments
Table 90. Mydecine Innovations Group Company Summary
Table 91. Mydecine Innovations Group Psychedelic Drugs Product Offerings
Table 92. Mydecine Innovations Group Psychedelic Drugs Revenue (US$, Mn) & (2018-2023)
Table 93. Mydecine Innovations Group Key News & Latest Developments
Table 94. Red Light Holland Company Summary
Table 95. Red Light Holland Psychedelic Drugs Product Offerings
Table 96. Red Light Holland Psychedelic Drugs Revenue (US$, Mn) & (2018-2023)
Table 97. Red Light Holland Key News & Latest Developments
Table 98. Braxia Scientific Company Summary
Table 99. Braxia Scientific Psychedelic Drugs Product Offerings
Table 100. Braxia Scientific Psychedelic Drugs Revenue (US$, Mn) & (2018-2023)
Table 101. Braxia Scientific Key News & Latest Developments
Table 102. Mind Cure Health Company Summary
Table 103. Mind Cure Health Psychedelic Drugs Product Offerings
Table 104. Mind Cure Health Psychedelic Drugs Revenue (US$, Mn) & (2018-2023)
Table 105. Mind Cure Health Key News & Latest Developments
Table 106. Entheon Biomedical Company Summary
Table 107. Entheon Biomedical Psychedelic Drugs Product Offerings
Table 108. Entheon Biomedical Psychedelic Drugs Revenue (US$, Mn) & (2018-2023)
Table 109. Entheon Biomedical Key News & Latest Developments
List of Figures
Figure 1. Psychedelic Drugs Segment by Type in 2022
Figure 2. Psychedelic Drugs Segment by Application in 2022
Figure 3. Global Psychedelic Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Psychedelic Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Psychedelic Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Psychedelic Drugs Revenue in 2022
Figure 8. By Type - Global Psychedelic Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Psychedelic Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Psychedelic Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Psychedelic Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Psychedelic Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Psychedelic Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Psychedelic Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Psychedelic Drugs Revenue Market Share, 2018-2030
Figure 16. US Psychedelic Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Psychedelic Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Psychedelic Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Psychedelic Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Psychedelic Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Psychedelic Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Psychedelic Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Psychedelic Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Psychedelic Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Psychedelic Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Psychedelic Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Psychedelic Drugs Revenue Market Share, 2018-2030
Figure 28. China Psychedelic Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Psychedelic Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Psychedelic Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Psychedelic Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Psychedelic Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Psychedelic Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Psychedelic Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Psychedelic Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Psychedelic Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Psychedelic Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Psychedelic Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Psychedelic Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Psychedelic Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. COMPASS Pathways PLC Psychedelic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer Psychedelic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Eli Lilly Psychedelic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. GlaxoSmithKline Psychedelic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Cybin Inc Psychedelic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Field Trip Health Psychedelic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. ATAI Life Sciences Psychedelic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. NUMINUS WELLNESS Psychedelic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. MindMed Psychedelic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. HAVN Life Sciences Psychedelic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Seelos Therapeutics Psychedelic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Jannsen Psychedelic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Acadia Pharmaceuticals Psychedelic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Intellipharmaceutics Psychedelic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Revive Therapeutics Psychedelic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Mydecine Innovations Group Psychedelic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Red Light Holland Psychedelic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Braxia Scientific Psychedelic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Mind Cure Health Psychedelic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Entheon Biomedical Psychedelic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
